⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21525610 | 0.58 | — | — | |
| Water SCHEMBL25437472 | 0.00 | — | — | |
| SCHEMBL25434707 | 0.00 | — | — | |
| SCHEMBL23644895 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462161 | 0.00 | CA4 (0.50) | — | |
| SCHEMBL25396888 | 0.00 | — | — | |
| SCHEMBL25438576 | 0.00 | — | — | |
| Methane SCHEMBL23929073 | 0.00 | — | — | |
| SCHEMBL25436537 | 0.00 | — | — | |
| Potassium Ion SCHEMBL23462037 | 0.00 | CA4 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4352233-A1 | CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION | The Trustees of Columbia University in the City of New York (US) | 2024-04-17 | — | — | EP | disclosed |
| WO-2024025895-A2 | AIR CONTACTOR | BALTIMORE AIRCOIL COMPANY, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2022261122-A1 | CRISPR-TRANSPOSON SYSTEMS FOR DNA MODIFICATION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2021126553-A1 | IN-SITU ADDITIVE IMPLANTS | WARSAW ORTHOPEDIC, INC (US) | 2021-06-24 | — | — | WO | disclosed |
| EP-3818161-A1 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND DISORDERS ASSOCIATED WITH THE SPINAL CORD | Voyager Therapeutics, Inc. (US) | 2021-05-12 | — | — | EP | disclosed |
| EP-3793616-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AAV | Voyager Therapeutics, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3737233-A1 | GROWTH FACTOR OTIC FORMULATIONS | Otonomy, Inc. (US) | 2020-11-18 | — | — | EP | disclosed |
| EP-3707149-A1 | SELENOGALACTOSIDE COMPOUNDS FOR THE TREATMENT OF SYSTEMIC INSULIN RESISTANCE DISORDERS AND THE USE THEREOF | Galectin Sciences, LLC (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3707266-A1 | TARGETED INTEGRATION SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | Editas Medicine, Inc. (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3694520-A1 | COMPOSITIONS AND METHODS FOR TREATING DIFFUSE LARGE B CELL LYMPHOMA | Merck Sharp & Dohme Corp. (US) | 2020-08-19 | — | — | EP | disclosed |
| EP-2023930-A1 | IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE | N.V. Organon (NL) | 2009-02-18 | — | — | EP | disclosed |
| WO-2008020866-A1 | IONIZABLE INHIBITORS OF FATTY ACID AMIDE HYDROLASE | N.V. ORGANON | 2008-02-21 | — | — | WO | disclosed |
| WO-2007139653-A1 | LCD FILMS OR SHEETS COMPRISING FILMS COMPRISING POLYESTER COMPOSITIONS FORMED FROM 2,2,4,4,-TETRAMETHYL-1,3-CYCLOBUTANEDIOL AND 1,4-CYCLOHEXANEDIMETHANOL | EASTMAN CHEMICAL COMPANY (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007139663-A1 | POLYESTER COMPOSITIONS WHICH COMPRISE CYCLOBUTANEDIOL AND CERTAIN THERMAL STABILIZERS, AND/OR REACTION PRODUCTS THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007098184-A2 | METHODS AND COMPOSITIONS FOR ANALYTE DETECTION | NANOGEN, INC. (US) | 2007-08-30 | — | — | WO | disclosed |
| EP-1809214-A2 | CROSSBAR SPINAL PROSTHESIS HAVING A MODULAR DESIGN AND SYSTEM FOR TREATING SPINAL PATHOLOGIES | ARCHUS ORTHOPEDICS INC. (US) | 2007-07-25 | — | — | EP | disclosed |
| WO-2007075836-A2 | METHODS FOR DETECTION OF GENETIC DISORDERS | RAVGEN, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| EP-1765789-A1 | N-(1-(1-BENZYL-4-PHENYL-1H-IMIDAZOL-2-YL)-2,2-DIMETHYLPROPYL)BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCER | Novartis Vaccines and Diagnostics, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2006055186-A2 | SPINAL PROSTHESIS HAVING A MODULAR DESIGN | ARCHUS ORTHOPEDICS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |
| WO-2006002236-A1 | N- (1- (1-BENZYL -4-PHENYL-1H-IMIDAZOL-2-YL) -2,2-DYMETHYLPROPYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS KINESIN SPINDLE PROTEIN (KSP) INHIBITORS FOR THE TREATMENT OF CANCER | NOVARTIS VACCINES AND DIAGNOSTICS INC. (US) | 2006-01-05 | — | — | WO | disclosed |